单位：[1]GI Cancer Research Institute,Tongji Hospital,Huazhong University of Science and Technology,Wuhan 430030,P.R. China胃肠肿瘤研究所华中科技大学同济医学院附属同济医院[2]Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, P.R. China
This work was supported by NSFC (nos.
81874186 and 82273254 to J.H; 81874148 to J.W.; 81974432 and
81922053 to G.W; and 82203142 to D.S.), the Key R&D Program of Hubei
Province (2020BCB019, J.H.), and startup funding from Tongji Hospital for
G.W.
第一作者单位：[1]GI Cancer Research Institute,Tongji Hospital,Huazhong University of Science and Technology,Wuhan 430030,P.R. China
通讯作者：
推荐引用方式(GB/T 7714)：
Li Xun,Song Da,Chen Yaqi,et al.NSD2 methylates AROS to promote SIRT1 activation and regulates fatty acid metabolism-mediated cancer radiotherapy[J].CELL REPORTS.2023,42(10):doi:10.1016/j.celrep.2023.113126.
APA：
Li Xun,Song Da,Chen Yaqi,Huang Changsheng,Liu Anyi...&Hu Junbo.(2023).NSD2 methylates AROS to promote SIRT1 activation and regulates fatty acid metabolism-mediated cancer radiotherapy.CELL REPORTS,42,(10)
MLA：
Li Xun,et al."NSD2 methylates AROS to promote SIRT1 activation and regulates fatty acid metabolism-mediated cancer radiotherapy".CELL REPORTS 42..10(2023)
生物学